N
Description
Norwegian clinical-stage biopharmaceutical company dedicated to discovering and developing novel immunotherapies. Vaccibody platform for therapeutic vaccines targeting antigen-presenting cells (APCs). Lead products: VB10.16 (HPV16, cervical/head-neck cancer, Phase 2), VB10.NEO (individualized neoantigen vaccine, licensed to Genentech/Roche). Partnerships with Regeneron. Listed on Oslo Stock Exchange. Based in Oslo.